Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Sedatives Stories

95b48d50491728f9bff5589878bbd3b91
2010-08-18 13:30:00

Swiss scientists suggested Wednesday that psychedelic drugs like LSD, ketamine and magic mushrooms could be combined with psychotherapy to treat people suffering from depression, compulsive disorders or chronic pain. Research into the effects of psychedelics has been restricted because of the negative connotations of drugs, but the scientists said more studies into their clinical potential were now justified. The scientists reported that recent brain imaging studies show that psychedelics...

2010-07-05 08:59:00

TEL AVIV, Israel, July 5, 2010 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.Neurim.com) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over. The approval was based primarily on data obtained in the latest SOUNDER-SLEEP Phase IV clinical study, indicating that Circadin was safe and more effective...

2010-06-07 14:03:44

When seizures strike, the most immediate goal for caregivers is to get appropriate medication to the patient as quickly as possible to stop the seizing activity. In a paper published in the June Academic Emergency Medicine, UC emergency medicine assistant professor Jason McMullan, MD, found that the best means of stopping status epilepticus (SE) may be with the least direct medication. In the meta-analysis, McMullan compiled the results of six studies featuring 774 patients. His analysis...

2237edbbcbca7d3a21083dd293a43e1f1
2010-06-07 06:40:00

Individuals with chronic insomnia have an elevated risk of death, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that the adjusted hazard ratio for all-cause mortality was three times higher in people with chronic insomnia (HR = 3.0) than in people without insomnia.  When examining individual subtypes of insomnia, the risk of...

2010-04-27 13:34:00

WASHINGTON, April 27 /PRNewswire-USNewswire/ -- AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services' Health Care Fraud Enforcement Action Team (HEAT) announced today. Such unapproved uses are also known as "off-label" uses because they...

2010-04-15 10:35:00

NORTH KINGSTOWN, R.I., April 15 /PRNewswire/ -- Unintentional poisoning deaths have dramatically increased over the last decade to become the second leading cause of injury deaths in the United States. Along with this trend, the number of Emergency Room visits and resulting hospitalizations has also increased. According to a recent study conducted by the West Virginia School of Medicine, hospitalizations for poisonings from overdoses of prescription opioids, sedatives and tranquilizers...

2010-03-10 15:00:00

FORT LEE, N.J., March 10 /PRNewswire/ -- Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), today announced that the U.S. Food and Drug Administration (FDA) recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review. "We are pleased that the lurasidone NDA has been accepted for...

015fb73ceab6228fb711228c2d2b53261
2010-02-24 12:17:28

The UN's top global drug regulator said on Wednesday that more people are turning to prescription drug abuse than cocaine, heroin and ecstasy combined. The International Narcotics Control Board (INCB) said that use of "date-rape drugs" is climbing as well, as sexual predators find new ways to get around the tight controls on substances by switching to drugs not banned by international drug laws. Drugs like ketamine and gamma-Butyrolactone (GBL) have replaced Rohypnol, which was one of the...

2010-02-22 15:35:00

POINT RICHMOND, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today an update on its plans to seek U.S. Food and Drug Administration (FDA) approval of Intermezzo® (zolpidem tartrate sublingual tablet) for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. Transcept met with the FDA on January 20, 2010 to discuss the Complete Response Letter...

230055f97bcfdfb0067ea16615d2d9881
2010-02-11 06:50:00

Scientists announced Wednesday they have solved the mystery behind why people become addicted to a class of prescription drugs that includes some anti-depressants, muscle relaxants and sleeping pills, reported AFP. Reported in the British science journal Nature, researchers hope the findings will pave the way for the development of new treatments that can alleviate symptoms without resulting in addiction. Scientists know that drugs like opium, heroin and cannabinoids are addictive because...